Problems with Prostate-Specific Antigen Screening: A Critical Review
- 1 January 2003
- book chapter
- Published by Springer Nature
- Vol. 163, 226-231
- https://doi.org/10.1007/978-3-642-55647-0_20
Abstract
The effect of population screening with regard to reduction of prostate cancer specific mortality and quality of life issues is not yet clear. Several national and international prospective studies are currently being conducted to answer these important questions. They include the trials in the Federal State of Tyrol, Austria and in the Quebec City area, Canada, as well as the Prostate, Lung, Colorectal and Ovarian (PLCO) trial in the United States and the European Randomized Study of Screening for Prostate Cancer (ERSPC). In the meantime, individual case finding (opportunistic screening) is recommended for men with a life-expectancy of at least 10 years.Keywords
This publication has 12 references indexed in Scilit:
- The rise and fall of PSA: clinical implications of prostate specific antigen kinetics.Urological Research, 2002
- No randomised trial of prostatecancer screening in NorwayThe Lancet Oncology, 2001
- Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortalityEuropean Journal Of Cancer Prevention, 2001
- Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, AustriaUrology, 2001
- Health-Related Quality-of-Life Effects of Radical Prostatectomy and Primary Radiotherapy for Screen-Detected or Clinically Diagnosed Localized Prostate CancerJournal of Clinical Oncology, 2001
- EAU guidelines on prostate cancer.European Urology, 2001
- Prostate-specific antigen-based early detection of prostate cancer—validation of screening without rectal examinationUrology, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Screening decreases prostate cancer death: First analysis of the 1988 Quebec Prospective Randomized Controlled TrialThe Prostate, 1999
- Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer InstituteJournal of Urology, 1994